• Yanqing Chen, Yusheng Yao, Yihuan Wu, Dongsheng Dai, Qiuyan Zhao, and Liangcheng Qiu.
• Department of Anesthesiology, The Shengli Clinical Medical College of Fujian Medical University & Fujian Provincial Hospital Fuzhou 350001, China.
• Int J Clin Exp Med. 2015 Jan 1;8(4):5781-7.

BackgroundIn this prospective, randomized, double-blind study, we verified the hypothesis that TEAS can alleviate remifentanil-induced hyperalgesia in patients undergoing thyroidectomy.Methods60 American Society of Anesthesiologists physical status (ASA) I-IIpatients, aged 18-60 year, scheduled for thyroidectomy were randomly allocated to TEAS or sham groups. TEAS consisted of 30 min of stimulation (6-9 mA, 2/10 Hz) on the Hegu (LI4) and Neiguan (PC6) before anesthesia. Anesthesia was maintained with sevoflurane adjusted to bispectral index (40-60) and target remifentanil 5.0 ng/ml. Mechanical pain thresholds were assessed using electronic von Frey. The primary outcome was mechanical pain thresholds. Secondary outcomes included postoperative pain scores, the time to first rescue analgesic, cumulative number of rescue analgesia, and side effects, including postoperative nausea and vomiting (PONV), dizziness and shivering in 24 h postoperatively.ResultsBaseline mechanical pain thresholds were similar between the groups. The analysis revealed the decrease in mechanical threshold was greater in the sham group than the TEAS group (P < 0.001). Postoperative pain scores and cumulative number of rescue analgesia were lower in the TEAS group (P < 0.05). In addition, TEAS group patients reduced the incidence of PONV and shivering.ConclusionPreoperative TEAS can attenuate remifentanil-induced hyperalgesia in patients undergoing thyroidectomy.

4 keywords...

hide…